HRMY
Harmony Biosciences Holdings Inc Earnings
$26.52
Earnings Summary
Revenue | $243.78Mn |
Net Profits | $22.49Mn |
Net Profit Margins | 9.22% |
Harmony Biosciences Holdings Inc’s revenue jumped 21.12% since last year same period to $243.78Mn in the Q4 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 1.8% jump in its revenue since last 3-months.
Harmony Biosciences Holdings Inc’s net profit fell -54.55% since last year same period to $22.49Mn in the Q4 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated -55.79% fall in its net profits since last 3-months.
Harmony Biosciences Holdings Inc’s net profit margin fell -62.48% since last year same period to 9.22% in the Q4 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated -56.58% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.9 |
EPS Estimate Current Year | 0.9 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.9 - a 4.38% jump from last quarter’s estimates.
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.9.
Key Ratios
Earning Per Share (EPS) | 0 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Harmony Biosciences Holdings Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-05 | 0.9 | 0 | -100% |
